G-CSF and plerixafor

DRUG2 trials

Sponsors

Genzyme, a Sanofi Company, Insel Gruppe AG, University Hospital Bern

Conditions

Lymphoma, Non-HodgkinMultiple MyelomaMyeloma

Phase 2

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

CompletedNCT00322387

Genzyme, a Sanofi CompanyLymphoma, Non-Hodgkin, Multiple Myeloma

Start: 2004-04-30End: 2006-07-31Updated: 2014-03-13

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

CompletedNCT01220375

Insel Gruppe AG, University Hospital BernMyeloma

Start: 2010-04-30End: 2013-10-31Updated: 2014-04-17